Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PIALOUX

Showing results (441-450 of 578) with videos related to

Pageof 58
Sort By:
AIDS (London, England)|January 28, 2006
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIVKarine Lacombe, Véronique Massari, Pierre-Marie Girard, et al.
Frontiers in Neurology|January 10, 2018
Plasma Exosomes and Improvements in Endothelial Function by Angiotensin 2 Type 1 Receptor or Cyclooxygenase 2 Blockade following Intermittent HypoxiaAbdelnaby Khalyfa, Nina Youssefnia, Glen E Foster, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|May 31, 2019
Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination PreventionCostanza Puppo, Xavier Mabire, Laurent Cotte, et al.
AIDS (London, England)|April 18, 2023
Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIVMaria-Bernarda Requena, Sophie Grabar, Emilie Lanoy, et al.
Antiviral Therapy|July 1, 1997
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapyD Mathez, P Bagnarelli, I Gorin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY TrialPerrine Roux, Lisa Fressard, Marie Suzan-Monti, et al.
The Journal of Infectious Diseases|July 2, 2017
Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis ProgramsConstance Delaugerre, Guillemette Antoni, Nadia Mahjoub, et al.
AIDS Research and Human Retroviruses|November 13, 2008
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteersBenjamin Silbermann, Michel Tod, Corinne Desaint, et al.
HIV Clinical Trials|January 19, 2016
Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral AgentsJùrgen K Rockstroch, Vicente Soriano, Frank Plonski, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2020
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSMAnders Boyd, Patrick Miailhes, Julie Chas, et al.
Pageof 58

Showing results (441-450 of 578) with videos related to

Sort By:
Pageof 58
AIDS (London, England)|January 28, 2006
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIVKarine Lacombe, Véronique Massari, Pierre-Marie Girard, et al.
Frontiers in Neurology|January 10, 2018
Plasma Exosomes and Improvements in Endothelial Function by Angiotensin 2 Type 1 Receptor or Cyclooxygenase 2 Blockade following Intermittent HypoxiaAbdelnaby Khalyfa, Nina Youssefnia, Glen E Foster, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|May 31, 2019
Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination PreventionCostanza Puppo, Xavier Mabire, Laurent Cotte, et al.
AIDS (London, England)|April 18, 2023
Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIVMaria-Bernarda Requena, Sophie Grabar, Emilie Lanoy, et al.
Antiviral Therapy|July 1, 1997
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapyD Mathez, P Bagnarelli, I Gorin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY TrialPerrine Roux, Lisa Fressard, Marie Suzan-Monti, et al.
The Journal of Infectious Diseases|July 2, 2017
Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis ProgramsConstance Delaugerre, Guillemette Antoni, Nadia Mahjoub, et al.
AIDS Research and Human Retroviruses|November 13, 2008
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteersBenjamin Silbermann, Michel Tod, Corinne Desaint, et al.
HIV Clinical Trials|January 19, 2016
Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral AgentsJùrgen K Rockstroch, Vicente Soriano, Frank Plonski, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2020
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSMAnders Boyd, Patrick Miailhes, Julie Chas, et al.
Pageof 58